Communicable Diseases  >>  hydrocortisone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
COIITSS, NCT00320099: Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock

Completed
3
508
Europe
recombinant human insulin, hydrocortisone, fludrocortisone, Hydrocortisone
University of Versailles, Assistance Publique - Hôpitaux de Paris
Septic Shock
01/09
02/09
CORTIFLU, NCT01014364: Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu

Terminated
3
40
Europe
hydrocortisone, hydrocortisone acetate, isotonic saline, normal saline
University of Versailles, Assistance Publique - Hôpitaux de Paris
Pneumonia, Viral, Influenza in Humans
06/11
12/11
NCT02114710: Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock

Completed
3
240
RoW
Hydrocortisone
Nanjing PLA General Hospital
Coagulation Dysfunction in Septic Shock, Hemodynamic Improvement Induced by Hydrocortisone
10/12
10/12
Corti-TC, NCT01093261: Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury

Completed
3
336
Europe
Placebo, Hydrocortisone Fludrocortisone
Nantes University Hospital, Société Française d'Anesthésie et de Réanimation
Traumatic Brain Injury, Trauma, Adrenal Insufficiency, Pneumonia
11/12
12/12
HYPRESS, NCT00670254 / 2007-004401-10: Hydrocortisone for Prevention of Septic Shock

Completed
3
380
Europe
Placebo, Hydrocortisone
Charite University, Berlin, Germany, German Federal Ministry of Education and Research, SepNet - Critical Care Trials Group, Coordination Centre for Clinical Trials Leipzig
Severe Sepsis
08/13
08/13
NCT02266589: Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock

Completed
3
84
RoW
Hydrocortisone
Nanjing PLA General Hospital
Septic Shock, Sepsis
10/13
10/13
APROCCHS, NCT00625209 / 2007-004485-40: Activated Protein C and Corticosteroids for Human Septic Shock

Completed
3
1241
Europe
placebos, hydrocortisone and fludrocortisone and placebo, recombinant human activated protein C and placebos, recombinant human activated protein C and hydrocortisone and fludrocortisone
University of Versailles, Assistance Publique - Hôpitaux de Paris, Ministry of Health, France
Septic Shock
06/15
07/16
NCT01595048 / 2010-019224-31: Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia

Active, not recruiting
2/3
640
US, Canada, RoW
Rituximab, MOAB IDEC-C2B8, Prednisone, Etoposide, Lastet, Doxorubicin Hydrochloride, Cytarabine, CHX-3311, U-19920, Vincristine Sulfate, Kyocristine, Oncovin, VCR, Vincasar, Cyclophosphamide, Methotrexate, Methylprednisolone, MePRDL, Leucovorin Calcium, CF, Therapeutic Hydrocortisone, Aeroseb-HC, Cetacort, HC, Laboratory Biomarker Analysis
Children's Oncology Group, National Cancer Institute (NCI)
Childhood B Acute Lymphoblastic Leukemia, Childhood Burkitt Leukemia, Childhood Diffuse Large Cell Lymphoma, Mediastinal (Thymic) Large B-Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma
12/20
12/20

Download Options